The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sun., Sep. 21, 10:06 AM

Slide #21. Aastrom Biosciences, Inc. Secondary Offering

Company: Aastrom Biosciences, Inc. (NASDAQ:ASTM)
Date announced: 9/11/2014
Shares Offered: 13,725,490
Date of Pricing: 9/11/2014
Price Per Share: $2.55
Closed Date: 9/17/2014
Secondary Offering Details: Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced that it has priced a public offering of 13,725,490 shares of its common stock at a price to the public of $2.55 per share. Aastrom has also granted the underwriters a 30-day option to purchase up to an additional 2,058,823 shares of common stock. The offering is expected to close on or about September 16, 2014, subject to customary closing conditions.

Aastrom Biosciences is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. Co. is developing expanded multicellular therapies for use in the treatment of severe, chronic ischemic cardiovascular diseases. Ixmyelocel-T is a disease modifying therapy with multi-functional properties including: tissue remodeling, immuno-modulation and the promotion of angiogenesis. Co.'s cell-manufacturing technology enables the manufacture of multicellular therapies, expanded from an adult's own bone marrow, and delivered directly to damaged tissues.
Open the ASTM Page at The Online Investor »

Company Name:  Aastrom Biosciences Inc.
Sector:  Biotechnology

Open the ASTM Page at The Online Investor (in a new window) »

September 21, 2014    10:06 AM Eastern
Quotes delayed 20 minutes

Hold (2.50 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.